FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy as a Treatment for Women with Advanced Ovarian Cancer Following Initial Surgery

Avastin is now approved for ten distinct uses across six different types of cancer in the United States.

SOUTH SAN FRANCISCO, Calif. – June 13, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection.

Most Early-Stage Breast Cancer Patients Can Safely Avoid Chemotherapy, According to Landmark TAILORx Results Presented at ASCO 2018 and Published in The New England Journal of Medicine

Seventy percent of early-stage breast cancer patients can safely forego
chemotherapy and use hormonal therapy alone (such as Arimidex®, tamoxifen or
Faslodex®), according to the long-awaited results of the landmark TAILORx (Trial
Assigning IndividuaLized Options for Treatment (Rx)) study presented at the 2018
American Society of Clinical Oncology (ASCO) Annual Meeting on June 3. The
largest-ever breast cancer treatment study, TAILORx is a prospective, randomized
clinical trial sponsored by the NCI and designed to more precisely define the
effect of chemotherapy for women with Oncotype DX Breast Recurrence Score®

Rebecca’s Story: Running Through Breast Cancer

Rebecca’s Story: Running Through Breast Cancer

In early 2009 as I was doing a self-breast exam, I felt a lump.  I wasn’t too concerned because I knew my mom had had several benign lumps and figured it was probably the same.  I waited a couple of months until my next woman wellness visit. When I told my doctor about it, she felt the lump too but said women my age (34) get lumps.

Connie’s Story: 5 Tips for Going through Cancer

Connie’s Story: 5 Tips for Going through Cancer

5 Tips for Going Through Cancer
It’s been eighteen years since I had treatment for triple-negative breast cancer. Looking back, the things that were helpful then have served me ever since. I’m not an expert, and what works for one person may not for another, but I’ll share these tips with you hoping you’ll find something useful for getting through this time in your life.

May 8 is World Ovarian Cancer Day!

On May 8, people around the world are gathering to support awareness of ovarian cancer. Join SHARE by following us on Facebook, Twitter, and Instagram, where we’ll be posting about signs, symptoms, and stories you can share with the women in your life.

SHARE’s Annual Volunteer Party

April is National Volunteer Appreciation Month, and SHARE hosted its annual volunteer party to show how much we appreciate the incredible commitment of our volunteers. It was another great gathering with a raffle, food, music, and of course, amazing company.

Victoria: Living with HER2+ Metastatic Breast Cancer

Victoria: Living with HER2+ Metastatic Breast Cancer

My original cancer diagnosis was on Valentine’s Day of 2005.  I was 44 years old, had a busy career, a husband and two young sons.  During a routine gynecological exam my doctor found a small lump in my right breast. Subsequent tests confirmed a 1 cm invasive ductal carcinoma.

National Helpline: